Leqembi Launch Set For Germany & Austria After Winning EU Approval At Last

 
• By Neena Brizmohun
  
Concept of a human head with a puzzle in the middle.
Leqembi is the first therapy that targets an underlying cause of AD to be authorized in the EU (Shutterstock)

More from Approvals

More from Market Access